ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharma and Health Care Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-19L9258
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharma and Health Care Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pharma and Health Care Market Research Report 2024

Code: QYRE-Auto-19L9258
Report
March 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Novartis
Roche
AbbVie
Merck
Bristol–Myers Squibb
GlaxoSmithKline PLC
Pfizer Inc
Sanofi
Takeda
Astrazeneca plc
Bayer
Eli Lilly & Co
Gilead Sciences
Amgen Inc
Novo Nordisk
TEVA
Boehringer Ingelheim
Biogen
Astellas

Pharma and Health Care Market Size

The global Pharma and Health Care market was valued at US$ 1245880 million in 2023 and is anticipated to reach US$ 1644850 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.

Pharma and Health Care Market

Pharma and Health Care Market

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.
Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.
In this report, we mainly study the pharma and healthcare product.
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%.
Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.
This report aims to provide a comprehensive presentation of the global market for Pharma and Health Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma and Health Care.

Report Scope

The Pharma and Health Care market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharma and Health Care market comprehensively. Regional market sizes, concerning products by Format, by Prescription, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma and Health Care companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Format, by Prescription, and by regions.
Market Segmentation

Scope of Pharma and Health Care Market Report

Report Metric Details
Report Name Pharma and Health Care Market
Accounted market size in 2023 US$ 1245880 million
Forecasted market size in 2030 US$ 1644850 million
CAGR 4.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Format
  • Bottle
  • Blister
  • Others
Segment by Prescription
  • OTC Drugs
  • Prescription Drugs
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, AstraZeneca, Bayer, Eli Lilly & Co., Gilead Sciences, Amgen, Novo Nordisk, Teva, Boehringer Ingelheim, Biogen, Astellas
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Format, by Prescription, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharma and Health Care companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Format, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Prescription, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pharma and Health Care Market growing?

Ans: The Pharma and Health Care Market witnessing a CAGR of 4.0% during the forecast period 2024-2030.

What is the Pharma and Health Care Market size in 2030?

Ans: The Pharma and Health Care Market size in 2030 will be US$ 1644850 million.

What is the Pharma and Health Care Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 50%.

Who are the main players in the Pharma and Health Care Market report?

Ans: The main players in the Pharma and Health Care Market are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, AstraZeneca, Bayer, Eli Lilly & Co., Gilead Sciences, Amgen, Novo Nordisk, Teva, Boehringer Ingelheim, Biogen, Astellas

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Format
1.2.1 Global Pharma and Health Care Market Size Growth Rate by Format: 2019 VS 2023 VS 2030
1.2.2 Bottle
1.2.3 Blister
1.2.4 Others
1.3 Market by Prescription
1.3.1 Global Pharma and Health Care Market Growth by Prescription: 2019 VS 2023 VS 2030
1.3.2 OTC Drugs
1.3.3 Prescription Drugs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharma and Health Care Market Perspective (2019-2030)
2.2 Pharma and Health Care Growth Trends by Region
2.2.1 Global Pharma and Health Care Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharma and Health Care Historic Market Size by Region (2019-2024)
2.2.3 Pharma and Health Care Forecasted Market Size by Region (2025-2030)
2.3 Pharma and Health Care Market Dynamics
2.3.1 Pharma and Health Care Industry Trends
2.3.2 Pharma and Health Care Market Drivers
2.3.3 Pharma and Health Care Market Challenges
2.3.4 Pharma and Health Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharma and Health Care Players by Revenue
3.1.1 Global Top Pharma and Health Care Players by Revenue (2019-2024)
3.1.2 Global Pharma and Health Care Revenue Market Share by Players (2019-2024)
3.2 Global Pharma and Health Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharma and Health Care Revenue
3.4 Global Pharma and Health Care Market Concentration Ratio
3.4.1 Global Pharma and Health Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharma and Health Care Revenue in 2023
3.5 Pharma and Health Care Key Players Head office and Area Served
3.6 Key Players Pharma and Health Care Product Solution and Service
3.7 Date of Enter into Pharma and Health Care Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharma and Health Care Breakdown Data by Format
4.1 Global Pharma and Health Care Historic Market Size by Format (2019-2024)
4.2 Global Pharma and Health Care Forecasted Market Size by Format (2025-2030)
5 Pharma and Health Care Breakdown Data by Prescription
5.1 Global Pharma and Health Care Historic Market Size by Prescription (2019-2024)
5.2 Global Pharma and Health Care Forecasted Market Size by Prescription (2025-2030)
6 North America
6.1 North America Pharma and Health Care Market Size (2019-2030)
6.2 North America Pharma and Health Care Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharma and Health Care Market Size by Country (2019-2024)
6.4 North America Pharma and Health Care Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharma and Health Care Market Size (2019-2030)
7.2 Europe Pharma and Health Care Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharma and Health Care Market Size by Country (2019-2024)
7.4 Europe Pharma and Health Care Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharma and Health Care Market Size (2019-2030)
8.2 Asia-Pacific Pharma and Health Care Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharma and Health Care Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharma and Health Care Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharma and Health Care Market Size (2019-2030)
9.2 Latin America Pharma and Health Care Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharma and Health Care Market Size by Country (2019-2024)
9.4 Latin America Pharma and Health Care Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharma and Health Care Market Size (2019-2030)
10.2 Middle East & Africa Pharma and Health Care Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharma and Health Care Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharma and Health Care Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Pharma and Health Care Introduction
11.1.4 Johnson & Johnson Revenue in Pharma and Health Care Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Pharma and Health Care Introduction
11.2.4 Novartis Revenue in Pharma and Health Care Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Pharma and Health Care Introduction
11.3.4 Roche Revenue in Pharma and Health Care Business (2019-2024)
11.3.5 Roche Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Pharma and Health Care Introduction
11.4.4 AbbVie Revenue in Pharma and Health Care Business (2019-2024)
11.4.5 AbbVie Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Detail
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Pharma and Health Care Introduction
11.5.4 Merck & Co. Revenue in Pharma and Health Care Business (2019-2024)
11.5.5 Merck & Co. Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Detail
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Pharma and Health Care Introduction
11.6.4 Bristol Myers Squibb Revenue in Pharma and Health Care Business (2019-2024)
11.6.5 Bristol Myers Squibb Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Pharma and Health Care Introduction
11.7.4 GlaxoSmithKline Revenue in Pharma and Health Care Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Pharma and Health Care Introduction
11.8.4 Pfizer Revenue in Pharma and Health Care Business (2019-2024)
11.8.5 Pfizer Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Pharma and Health Care Introduction
11.9.4 Sanofi Revenue in Pharma and Health Care Business (2019-2024)
11.9.5 Sanofi Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Pharma and Health Care Introduction
11.10.4 Takeda Revenue in Pharma and Health Care Business (2019-2024)
11.10.5 Takeda Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Pharma and Health Care Introduction
11.11.4 AstraZeneca Revenue in Pharma and Health Care Business (2019-2024)
11.11.5 AstraZeneca Recent Development
11.12 Bayer
11.12.1 Bayer Company Detail
11.12.2 Bayer Business Overview
11.12.3 Bayer Pharma and Health Care Introduction
11.12.4 Bayer Revenue in Pharma and Health Care Business (2019-2024)
11.12.5 Bayer Recent Development
11.13 Eli Lilly & Co.
11.13.1 Eli Lilly & Co. Company Detail
11.13.2 Eli Lilly & Co. Business Overview
11.13.3 Eli Lilly & Co. Pharma and Health Care Introduction
11.13.4 Eli Lilly & Co. Revenue in Pharma and Health Care Business (2019-2024)
11.13.5 Eli Lilly & Co. Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Detail
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Pharma and Health Care Introduction
11.14.4 Gilead Sciences Revenue in Pharma and Health Care Business (2019-2024)
11.14.5 Gilead Sciences Recent Development
11.15 Amgen
11.15.1 Amgen Company Detail
11.15.2 Amgen Business Overview
11.15.3 Amgen Pharma and Health Care Introduction
11.15.4 Amgen Revenue in Pharma and Health Care Business (2019-2024)
11.15.5 Amgen Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Detail
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Pharma and Health Care Introduction
11.16.4 Novo Nordisk Revenue in Pharma and Health Care Business (2019-2024)
11.16.5 Novo Nordisk Recent Development
11.17 Teva
11.17.1 Teva Company Detail
11.17.2 Teva Business Overview
11.17.3 Teva Pharma and Health Care Introduction
11.17.4 Teva Revenue in Pharma and Health Care Business (2019-2024)
11.17.5 Teva Recent Development
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Detail
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Pharma and Health Care Introduction
11.18.4 Boehringer Ingelheim Revenue in Pharma and Health Care Business (2019-2024)
11.18.5 Boehringer Ingelheim Recent Development
11.19 Biogen
11.19.1 Biogen Company Detail
11.19.2 Biogen Business Overview
11.19.3 Biogen Pharma and Health Care Introduction
11.19.4 Biogen Revenue in Pharma and Health Care Business (2019-2024)
11.19.5 Biogen Recent Development
11.20 Astellas
11.20.1 Astellas Company Detail
11.20.2 Astellas Business Overview
11.20.3 Astellas Pharma and Health Care Introduction
11.20.4 Astellas Revenue in Pharma and Health Care Business (2019-2024)
11.20.5 Astellas Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Johnson & Johnson
Novartis
Roche
AbbVie
Merck
Bristol–Myers Squibb
GlaxoSmithKline PLC
Pfizer Inc
Sanofi
Takeda
Astrazeneca plc
Bayer
Eli Lilly & Co
Gilead Sciences
Amgen Inc
Novo Nordisk
TEVA
Boehringer Ingelheim
Biogen
Astellas
List of Tables
    Table 1. Global Pharma and Health Care Market Size Growth Rate by Format (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Bottle
    Table 3. Key Players of Blister
    Table 4. Key Players of Others
    Table 5. Global Pharma and Health Care Market Size Growth by Prescription (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Pharma and Health Care Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Pharma and Health Care Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Pharma and Health Care Market Share by Region (2019-2024)
    Table 9. Global Pharma and Health Care Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Pharma and Health Care Market Share by Region (2025-2030)
    Table 11. Pharma and Health Care Market Trends
    Table 12. Pharma and Health Care Market Drivers
    Table 13. Pharma and Health Care Market Challenges
    Table 14. Pharma and Health Care Market Restraints
    Table 15. Global Pharma and Health Care Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Pharma and Health Care Market Share by Players (2019-2024)
    Table 17. Global Top Pharma and Health Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma and Health Care as of 2023)
    Table 18. Ranking of Global Top Pharma and Health Care Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Pharma and Health Care Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Pharma and Health Care Product Solution and Service
    Table 22. Date of Enter into Pharma and Health Care Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Pharma and Health Care Market Size by Format (2019-2024) & (US$ Million)
    Table 25. Global Pharma and Health Care Revenue Market Share by Format (2019-2024)
    Table 26. Global Pharma and Health Care Forecasted Market Size by Format (2025-2030) & (US$ Million)
    Table 27. Global Pharma and Health Care Revenue Market Share by Format (2025-2030)
    Table 28. Global Pharma and Health Care Market Size by Prescription (2019-2024) & (US$ Million)
    Table 29. Global Pharma and Health Care Revenue Market Share by Prescription (2019-2024)
    Table 30. Global Pharma and Health Care Forecasted Market Size by Prescription (2025-2030) & (US$ Million)
    Table 31. Global Pharma and Health Care Revenue Market Share by Prescription (2025-2030)
    Table 32. North America Pharma and Health Care Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Pharma and Health Care Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Pharma and Health Care Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Pharma and Health Care Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Pharma and Health Care Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Pharma and Health Care Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Pharma and Health Care Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Pharma and Health Care Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Pharma and Health Care Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Pharma and Health Care Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Pharma and Health Care Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Pharma and Health Care Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Pharma and Health Care Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Pharma and Health Care Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Pharma and Health Care Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Johnson & Johnson Company Detail
    Table 48. Johnson & Johnson Business Overview
    Table 49. Johnson & Johnson Pharma and Health Care Product
    Table 50. Johnson & Johnson Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 51. Johnson & Johnson Recent Development
    Table 52. Novartis Company Detail
    Table 53. Novartis Business Overview
    Table 54. Novartis Pharma and Health Care Product
    Table 55. Novartis Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 56. Novartis Recent Development
    Table 57. Roche Company Detail
    Table 58. Roche Business Overview
    Table 59. Roche Pharma and Health Care Product
    Table 60. Roche Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 61. Roche Recent Development
    Table 62. AbbVie Company Detail
    Table 63. AbbVie Business Overview
    Table 64. AbbVie Pharma and Health Care Product
    Table 65. AbbVie Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 66. AbbVie Recent Development
    Table 67. Merck & Co. Company Detail
    Table 68. Merck & Co. Business Overview
    Table 69. Merck & Co. Pharma and Health Care Product
    Table 70. Merck & Co. Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 71. Merck & Co. Recent Development
    Table 72. Bristol Myers Squibb Company Detail
    Table 73. Bristol Myers Squibb Business Overview
    Table 74. Bristol Myers Squibb Pharma and Health Care Product
    Table 75. Bristol Myers Squibb Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 76. Bristol Myers Squibb Recent Development
    Table 77. GlaxoSmithKline Company Detail
    Table 78. GlaxoSmithKline Business Overview
    Table 79. GlaxoSmithKline Pharma and Health Care Product
    Table 80. GlaxoSmithKline Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 81. GlaxoSmithKline Recent Development
    Table 82. Pfizer Company Detail
    Table 83. Pfizer Business Overview
    Table 84. Pfizer Pharma and Health Care Product
    Table 85. Pfizer Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 86. Pfizer Recent Development
    Table 87. Sanofi Company Detail
    Table 88. Sanofi Business Overview
    Table 89. Sanofi Pharma and Health Care Product
    Table 90. Sanofi Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 91. Sanofi Recent Development
    Table 92. Takeda Company Detail
    Table 93. Takeda Business Overview
    Table 94. Takeda Pharma and Health Care Product
    Table 95. Takeda Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 96. Takeda Recent Development
    Table 97. AstraZeneca Company Detail
    Table 98. AstraZeneca Business Overview
    Table 99. AstraZeneca Pharma and Health Care Product
    Table 100. AstraZeneca Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 101. AstraZeneca Recent Development
    Table 102. Bayer Company Detail
    Table 103. Bayer Business Overview
    Table 104. Bayer Pharma and Health Care Product
    Table 105. Bayer Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 106. Bayer Recent Development
    Table 107. Eli Lilly & Co. Company Detail
    Table 108. Eli Lilly & Co. Business Overview
    Table 109. Eli Lilly & Co. Pharma and Health Care Product
    Table 110. Eli Lilly & Co. Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 111. Eli Lilly & Co. Recent Development
    Table 112. Gilead Sciences Company Detail
    Table 113. Gilead Sciences Business Overview
    Table 114. Gilead Sciences Pharma and Health Care Product
    Table 115. Gilead Sciences Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 116. Gilead Sciences Recent Development
    Table 117. Amgen Company Detail
    Table 118. Amgen Business Overview
    Table 119. Amgen Pharma and Health Care Product
    Table 120. Amgen Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 121. Amgen Recent Development
    Table 122. Novo Nordisk Company Detail
    Table 123. Novo Nordisk Business Overview
    Table 124. Novo Nordisk Pharma and Health Care Product
    Table 125. Novo Nordisk Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 126. Novo Nordisk Recent Development
    Table 127. Teva Company Detail
    Table 128. Teva Business Overview
    Table 129. Teva Pharma and Health Care Product
    Table 130. Teva Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 131. Teva Recent Development
    Table 132. Boehringer Ingelheim Company Detail
    Table 133. Boehringer Ingelheim Business Overview
    Table 134. Boehringer Ingelheim Pharma and Health Care Product
    Table 135. Boehringer Ingelheim Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 136. Boehringer Ingelheim Recent Development
    Table 137. Biogen Company Detail
    Table 138. Biogen Business Overview
    Table 139. Biogen Pharma and Health Care Product
    Table 140. Biogen Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 141. Biogen Recent Development
    Table 142. Astellas Company Detail
    Table 143. Astellas Business Overview
    Table 144. Astellas Pharma and Health Care Product
    Table 145. Astellas Revenue in Pharma and Health Care Business (2019-2024) & (US$ Million)
    Table 146. Astellas Recent Development
    Table 147. Research Programs/Design for This Report
    Table 148. Key Data Information from Secondary Sources
    Table 149. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharma and Health Care Market Size Comparison by Format (2024-2030) & (US$ Million)
    Figure 2. Global Pharma and Health Care Market Share by Format: 2023 VS 2030
    Figure 3. Bottle Features
    Figure 4. Blister Features
    Figure 5. Others Features
    Figure 6. Global Pharma and Health Care Market Size Comparison by Prescription (2024-2030) & (US$ Million)
    Figure 7. Global Pharma and Health Care Market Share by Prescription: 2023 VS 2030
    Figure 8. OTC Drugs Case Studies
    Figure 9. Prescription Drugs Case Studies
    Figure 10. Pharma and Health Care Report Years Considered
    Figure 11. Global Pharma and Health Care Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Pharma and Health Care Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Pharma and Health Care Market Share by Region: 2023 VS 2030
    Figure 14. Global Pharma and Health Care Market Share by Players in 2023
    Figure 15. Global Top Pharma and Health Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma and Health Care as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Pharma and Health Care Revenue in 2023
    Figure 17. North America Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Pharma and Health Care Market Share by Country (2019-2030)
    Figure 19. United States Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Pharma and Health Care Market Share by Country (2019-2030)
    Figure 23. Germany Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Pharma and Health Care Market Share by Region (2019-2030)
    Figure 31. China Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Pharma and Health Care Market Share by Country (2019-2030)
    Figure 39. Mexico Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Pharma and Health Care Market Share by Country (2019-2030)
    Figure 43. Turkey Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Pharma and Health Care Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Johnson & Johnson Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 46. Novartis Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 47. Roche Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 48. AbbVie Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 49. Merck & Co. Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 50. Bristol Myers Squibb Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 51. GlaxoSmithKline Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 52. Pfizer Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 53. Sanofi Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 54. Takeda Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 55. AstraZeneca Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 56. Bayer Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 57. Eli Lilly & Co. Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 58. Gilead Sciences Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 59. Amgen Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 60. Novo Nordisk Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 61. Teva Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 62. Boehringer Ingelheim Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 63. Biogen Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 64. Astellas Revenue Growth Rate in Pharma and Health Care Business (2019-2024)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmaceutical and Consumer Products Coding Equipment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-32H12616
Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Co-Packing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-13K12891
Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Nucleic Acid-based Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-27P12567
Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Digital Refractometers for Food and Pharmaceutical Industry Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-1D13243
Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions